Provided by Tiger Trade Technology Pte. Ltd.

iShares U.S. Pharmaceuticals ETF

101.53
-0.7400-0.72%
Post-market: 101.530.00000.00%19:30 EDT
Volume:74.09K
Turnover:7.53M
Market Cap:1.66B
PE:9.46
High:102.23
Open:102.02
Low:101.24
Close:102.27
52wk High:108.66
52wk Low:69.02
Shares:16.35M
Float Shares:16.35M
Volume Ratio:0.45
T/O Rate:0.45%
Dividend:1.43
Dividend Rate:1.41%
EPS(TTM):10.74
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Merck & Company (MRK)

TIPRANKS
·
Sep 08

AlzeCure Pharma to Present at Aktiedagen Event in Stockholm

Reuters
·
Sep 08

Merck KGaA (0O14) Gets a Hold from Barclays

TIPRANKS
·
Sep 08

Orchid Pharma Files FY 2025-26 Business Responsibility and Sustainability Report

TIPRANKS
·
Sep 08

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Intellia Therapeutics (NTLA) and Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
Sep 08

ASB Ventures-Backed Boundary Zhikong’s Navista eVTOL Navigation System Enters CAAC Airworthiness Review

Reuters
·
Sep 07

Novartis Cholesterol Setback Tests Hopes for Emerging Heart Disease Drugs

Reuters
·
Sep 07

Nvidia, TSMC, Salesforce, CrowdStrike, J&J Insider Shake‑Up

TIPRANKS
·
Sep 05

Top Johnson & Johnson Executive Makes Major Stock Move

TIPRANKS
·
Sep 05

Royalty Pharma Announces Update on Novartis’ Phase 3 Topline Results for Pelacarsen

THOMSON REUTERS
·
Sep 05

Royalty Pharma - Expects to Recoup Investment and Earn Modest Return Despite Pelacarsen Failure

THOMSON REUTERS
·
Sep 05

Estee Lauder Cos. Cl a Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 05

Bristol Myers Squibb Co. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 05

Merck & Co. Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 05

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

Dow Jones
·
Sep 05

Bristol-Myers Squibb Moves Into Depression Market With New Phase 2 Trial

TIPRANKS
·
Sep 05

Lilly Targets Type 1 Diabetes With New Tirzepatide Study: What Investors Should Watch

TIPRANKS
·
Sep 05

Merck Price Target Raised to $170.00/Share from $150.00 by Wells Fargo

Dow Jones
·
Sep 04

Drugmakers Halt Autoimmune Trials After Deaths, Life-Threatening Side Effects

Dow Jones
·
Sep 04

Wuhan Dazhong Dental Proposes Wang Hong as Executive Director to Replace Guo Jiaping

Reuters
·
Sep 04